MED24

MED24 (TRAP100) is a subunit of the Mediator/TRAP transcriptional coactivator complex that amplifies activator-driven transcription rather than serving as the primary activator-binding or RNA polymerase II-recruiting module (PMID:10406464, PMID:12093747). It does not directly contact nuclear receptors but is targeted to them through the ligand-dependent receptor-binding subunit TRAP220/MED1, and it carries an intrinsic transactivation function that enhances ligand-dependent transcription by thyroid hormone and vitamin D receptors (PMID:10406464). Within the complex MED24 forms a submodule with TRAP95 and TRAP150β/SUR2 and is required for retention of CDK8/SRB10, while complex integrity with RNA Pol II and most activators is preserved in its absence; loss of MED24 broadly attenuates transcriptional activation by diverse activators, defining a secondary amplifying role (PMID:12093747). MED24 cooperates specifically with MED1 to drive estrogen receptor-dependent transcription, controlling pubertal mammary ductal branching and ER target gene expression such as E2F1 and cyclin D1 (PMID:22331469). Across vertebrate and invertebrate development MED24 has cell-type-specific functions, including enteric nervous system precursor proliferation and rod photoreceptor differentiation in zebrafish (PMID:16396911, PMID:16582438) and ecdysone-triggered programmed cell death downstream of death-gene transcription in Drosophila (PMID:20063412), and its genetic ablation is lethal with severe malformations (PMID:12093747).

1. 1999 Medium

   Established how MED24 is incorporated into nuclear receptor signaling, showing it is recruited indirectly via TRAP220/MED1 yet carries an autonomous transactivation capacity.

   Evidence In vitro binding, co-IP, GAL4 tethering and reporter assays for TR/VDR activation

   PMID:10406464

   Open questions at the time

   • The structural basis of the MED24–TRAP220 interaction is undefined
   • Whether the intrinsic transactivation function operates within the intact complex in vivo is unresolved
2. 2002 High

   Defined MED24's position within Mediator architecture and its functional role, placing its submodule downstream of activator binding and Pol II recruitment as a transcriptional amplifier essential for development.

   Evidence Mouse knockout, biochemical fractionation of residual complex, co-IP, reporter assays in deficient cells

   PMID:12093747

   Open questions at the time

   • The mechanism by which the MED24/TRAP95/SUR2 submodule retains CDK8 is unknown
   • Which activator subsets depend most on this amplifying step is not delineated
3. 2006 High

   Demonstrated that MED24 has discrete, non-redundant developmental functions, controlling ENS precursor proliferation and acting cell-autonomously in pharyngeal mesendoderm.

   Evidence Zebrafish forward-genetic mutant, morpholino phenocopy, pH3 staining, cell transplantation

   PMID:16396911

   Open questions at the time

   • The transcriptional targets mediating ENS proliferation are not identified
   • How a general coactivator produces such tissue-restricted effects is unexplained
4. 2006 Medium

   Showed that individual Mediator subunits have divergent, even opposing, functions in CNS cell-fate decisions, distinguishing MED24 from the paralogous MED27.

   Evidence Comparative zebrafish mutant analysis with cell-type-specific retinal markers

   PMID:16582438

   Open questions at the time

   • The gene programs underlying rod versus amacrine fate differences are uncharacterized
   • Mechanism of subunit-specific selectivity is unknown
5. 2010 Medium

   Placed MED24 in the ecdysone-triggered cell death cascade at a step downstream of death-gene transcription, an unexpected role for a transcriptional coactivator.

   Evidence Drosophila mutants, caspase cleavage assays, expression analysis of rpr/hid

   PMID:20063412

   Open questions at the time

   • Whether the role is genuinely post-transcriptional or reflects effects on unmeasured target genes is unresolved
   • The molecular step controlled by MED24 in caspase activation is undefined
6. 2012 High

   Identified specific functional cooperation between MED24 and MED1 in estrogen receptor signaling, linking the subunit to mammary morphogenesis and ER target gene control.

   Evidence MED1/MED24 double heterozygous knockout mice, BrdU assay, reporter assays in MEFs, qRT-PCR of ER targets

   PMID:22331469

   Open questions at the time

   • The biochemical basis of MED24–MED1 cooperativity is not resolved
   • Whether this cooperation extends to receptors beyond ER is unknown
7. 2019 Low

   Linked MED24 expression to ERBB2 signaling in lung tumorigenesis, positioning it as a downstream transcriptional output of oncogenic signaling.

   Evidence Conditional mouse cancer models, transcriptome analysis, human signature overlap

   PMID:31248101

   Open questions at the time

   • The connection between ERBB2 and MED24 is correlative, not mechanistic
   • No direct demonstration that MED24 mediates the oncogenic phenotype
8. 2025 Low

   Connected human MED24 mutations to a neuroepithelial morphogenesis defect, extending its developmental roles to apicobasal cell-shape regulation in human cells.

   Evidence Patient-derived iPSC neuroepithelial model, live imaging (preprint)

   PMID:bio_10.1101_2025.05.16.654453

   Open questions at the time

   • Single patient line with compound heterozygous mutations and no rescue experiment
   • Transcriptional targets controlling apicobasal elongation are unidentified

• It remains unknown how a broadly required Mediator amplifier subunit achieves the cell-type-specific and post-transcriptional functions observed across tissues and species.
• No structural model of the MED24 submodule within Mediator
• Direct genomic targets in each developmental context are undefined
• Mechanism linking MED24 to apicobasal morphology and caspase activation unresolved